Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Massachusetts Chan Medical School, Worcester, Massachusetts.
Lifespan Health System, Department of Biostatistics, Epidemiology, and Research Design, Providence, Rhode Island.
Am J Perinatol. 2024 Jul;41(10):1285-1289. doi: 10.1055/a-2278-8948. Epub 2024 Feb 29.
Oligohydramnios (defined as amniotic fluid volume < 5 cm or deepest vertical pocket < 2 cm) is regarded as an ominous finding on prenatal ultrasound. Amniotic fluid, however, is not static, and to date, there have been no studies comparing perinatal outcomes in patients who are diagnosed with oligohydramnios that resolves and those who have persistent oligohydramnios.
This is a secondary analysis of a National Institutes of Health-funded retrospective cohort study of singleton gestations delivered at a tertiary care hospital between 2002 and 2013 with mild hypertensive disorders and/or fetal growth restriction (FGR). Maternal characteristics, delivery, and neonatal information were abstracted by trained research nurses. Patients with a diagnosis of oligohydramnios were identified, and those with resolved versus persistent oligohydramnios at the time of delivery were compared. The primary outcome was a composite of neonatal resuscitation at delivery: administration of oxygen, bag-mask ventilation, continuous positive airway pressure, intubation, chest compression, or cardiac medication administration. Secondary outcomes included FGR, timing, and mode of delivery.
Of 527 women meeting study criteria, 42 had oligohydramnios that resolved prior to delivery, whereas 485 had persistent oligohydramnios. There were no significant differences in patient demographics between groups. The gestational age at diagnosis was significantly lower for patients with resolved versus persistent oligohydramnios (median: 33.0 [interquartile range, IQR: 29.1-35.9] vs. 38.0 [IQR: 36.4-39.3], < 0.001). There was not a substantial difference in rate of neonatal resuscitation (41 vs. 32%, = 0.31). Patients with resolved oligohydramnios were more likely to have developed FGR than those with persistent oligohydramnios (55 vs. 36%, < 0.02). There were no significant differences for gestational age at delivery, birth weight, or neonatal intensive care unit admission.
Patients whose oligohydramnios resolved were diagnosed earlier yet had similar rates of neonatal resuscitation but higher rates of FGR than those who had persistent oligohydramnios.
· When diagnosed earlier in pregnancy, oligohydramnios was more likely to resolve prenatally.. · Patients who were diagnosed with oligohydramnios earlier in pregnancy had higher rates of FGR.. · There were no differences in the rates of the composite outcome of need for neonatal resuscitation when comparing those with resolved versus those with persistent oligohydramnios. No differences in composite neonatal morbidity were noted between those with resolved versus persistent oligohydramnios..
羊水过少(定义为羊水体积<5 厘米或最大垂直深度<2 厘米)被认为是产前超声检查中的一个不祥发现。然而,羊水并不是静态的,迄今为止,还没有研究比较过在诊断为羊水过少但已经缓解的患者和持续羊水过少的患者的围产儿结局。
这是一项对在 2002 年至 2013 年期间在一家三级保健医院分娩的患有轻度高血压疾病和/或胎儿生长受限(FGR)的单胎妊娠的美国国立卫生研究院资助的回顾性队列研究的二次分析。由经过培训的研究护士提取产妇特征、分娩和新生儿信息。确定了诊断为羊水过少的患者,并比较了在分娩时羊水过少已经缓解与持续存在的患者。主要结局是新生儿复苏的复合指标:吸氧、气囊面罩通气、持续气道正压通气、插管、胸外按压或心脏药物治疗。次要结局包括 FGR、分娩时机和分娩方式。
在符合研究标准的 527 名女性中,有 42 名患有在分娩前已缓解的羊水过少,而 485 名患有持续羊水过少。两组患者的人口统计学特征无显著差异。与持续羊水过少的患者相比,羊水过少已缓解的患者的诊断时孕周明显较低(中位数:33.0 [四分位距,IQR:29.1-35.9] 与 38.0 [IQR:36.4-39.3],<0.001)。新生儿复苏的发生率差异无统计学意义(41% 与 32%,=0.31)。与持续羊水过少的患者相比,羊水过少已缓解的患者更有可能发生 FGR(55% 与 36%,<0.02)。两组的分娩时孕周、出生体重或新生儿重症监护病房入院率均无显著差异。
在妊娠早期诊断的羊水过少患者更早被诊断出来,但新生儿复苏的发生率相似,但 FGR 的发生率高于持续羊水过少的患者。
· 在妊娠早期更早诊断时,羊水过少更有可能在产前缓解。
· 在妊娠早期更早诊断为羊水过少的患者,FGR 的发生率更高。
· 比较羊水过少已缓解与持续存在的患者,新生儿复苏综合结局需要的发生率无差异。与持续羊水过少的患者相比,在复合新生儿发病率方面没有差异。